About CRADLE LIFE SCIENCES (PHARMA) PRIVATE LIMITED
CRADLE LIFE SCIENCES (PHARMA) PRIVATE LIMITED is a Private Limited Company and was incorporated on Feb 13, 2020 in India. It is registered at Registrar of Companies, ROC Patna. Its registered address is M.I.G. 37, HOUSING COLONY KANKARBAGH, P.O.- LOHIA NAGAR, Patna, PATNA, Bihar, India, 800020. Its corporate identification number is (CIN) U51909BR2020PTC045461 and its current status is Active. Its industry classification as per MCA is other Wholesale N.E.C.
CRADLE LIFE SCIENCES (PHARMA) PRIVATE LIMITED's last Annual General Meeting (AGM) was held on Sep 30, 2025 as per records from Ministry of Corporate Affairs (MCA). CRADLE LIFE SCIENCES (PHARMA) PRIVATE LIMITED's authorised share capital is ₹10L and its paid up capital is ₹7L. The current board of directors of CRADLE LIFE SCIENCES (PHARMA) PRIVATE LIMITED comprises Prashant Dubey, Rajnish Pandey and 5 more.
CRADLE LIFE SCIENCES (PHARMA) PRIVATE LIMITED generated less than ₹10 Cr in revenue for the financial year ending on Mar 31, 2025.
Contact Details for CRADLE LIFE SCIENCES (PHARMA) PRIVATE LIMITED
- *****@cradlelifesciences.com
- Registered Address
- M.I.G. 37, HOUSING COLONY KANKARBAGH, P.O.- LOHIA NAGAR, Patna, PATNA, Bihar, India, 800020
Brands associated with CRADLE LIFE SCIENCES (PHARMA) PRIVATE LIMITED
Name | Short Description | Founded Year | Location | Current Stage |
|---|---|---|---|---|
Provider of pharmaceutical products and skill development programs for individuals | - | Unfunded |
Principal Business Activity of CRADLE LIFE SCIENCES (PHARMA) PRIVATE LIMITED
Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations | yai |
Documents of CRADLE LIFE SCIENCES (PHARMA) PRIVATE LIMITEDFY 25 Available15 mins
Filing Summary
Here is a summary of filing activity and document availability across financial years:
File Type | FY 24-25 | FY 23-24 | FY 22-23 | FY 21-22 | FY 20-21 |
|---|---|---|---|---|---|
Financial Statements | |||||
Annual Returns |
Latest Financials, Share Allotment and Annual Report
The latest filed financial documents, annual reports, and share allotment filings are shown below:
Recent Filings
Below are the most recent filings submitted by the company:
Document Name | Category | Filing Date |
|---|---|---|
List of share holders, debenture holders | Annual Returns and Balance Sheet eForms | Dec 24, 2025 |
Photograph of the registered office of the Company showing external building and name prominently visible | Annual Returns and Balance Sheet eForms | Dec 24, 2025 |
Form MGT-7A | Annual Returns and Balance Sheet eForms | Dec 24, 2025 |
Copy of Financial Staements duly authenticated as per section 134 (Including Boards report, auditors report and other documents) | Annual Returns and Balance Sheet eForms | Nov 14, 2025 |
Form AOC-4 | Annual Returns and Balance Sheet eForms | Nov 14, 2025 |
e-Director?s Report | Annual Returns and Balance Sheet eForms | Nov 14, 2025 |
Form MGT-7A | Annual Returns and Balance Sheet eForms | Nov 20, 2024 |
List of Directors | Annual Returns and Balance Sheet eForms | Nov 20, 2024 |
List of share holders, debenture holders | Annual Returns and Balance Sheet eForms | Nov 20, 2024 |
Form AOC-4 | Annual Returns and Balance Sheet eForms | Oct 27, 2024 |
Financials of CRADLE LIFE SCIENCES (PHARMA) PRIVATE LIMITEDFY 25 Available15 mins
Financial Statement Summary
Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
Income Statement | |||||
Revenue | 1634 | 2520 | 9645 | 5969 | 6024 |
Total Sales | 1100 | 7254 | 6100 | 4002 | 5010 |
Total Expenses | 7971 | 2009 | 1900 | 6298 | 2806 |
Operating Expenses | 4463 | 8670 | 5014 | 6408 | 4808 |
Employee Expenses | 3716 | 9096 | 3597 | 5240 | 3812 |
Operating Income (EBIT) | 5221 | 1398 | 5342 | 2453 | 8820 |
Interest Expenses | 9419 | 3696 | 2207 | 3019 | 4541 |
Expenses from other activities | 4233 | 6525 | 2696 | 8798 | 2902 |
EBITDA | 9674 | 3191 | 7937 | 4689 | 6142 |
Taxes | 3336 | 1300 | 2480 | 4025 | 1641 |
Net Profit | 4639 | 8158 | 1970 | 5661 | 2287 |
Balance Sheet | |||||
Assets | 9355 | 9993 | 5135 | 2346 | 2495 |
Accounts Receivables | 2552 | 3589 | 3243 | 8984 | 6455 |
Inventory | 3790 | 6676 | 4346 | 2506 | 1466 |
Liabilities | 2487 | 9761 | 7599 | 9844 | 2191 |
Total Debt | 8966 | 8977 | 8635 | 9308 | 7569 |
Accounts Payable | 1709 | 3864 | 6021 | 5995 | 8324 |
Equities | 4208 | 7621 | 5969 | 4696 | 2491 |
Ratios
Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
Profitability Ratios | |||||
EBITDA Margin | 5244 | 6306 | 9979 | 5024 | 4747 |
EBIT Margin | 1073 | 4761 | 3261 | 9474 | 6606 |
Net Profit Margin | 8276 | 1780 | 5921 | 8005 | 5228 |
Return on Assets (ROA) | 8576 | 7096 | 1593 | 9649 | 7046 |
Return on Equity (ROE) | 4635 | 5301 | 9428 | 3157 | 6802 |
Return on Capital Employed | 3675 | 5939 | 5780 | 8048 | 7419 |
Return on Invested Capital | 2131 | 5733 | 7847 | 8364 | 5264 |
Efficiency Ratios | |||||
Asset Turnover | 7989 | 7767 | 1895 | 9700 | 3311 |
Receivables Turnover | 1515 | 1441 | 8275 | 7997 | 6580 |
Days Sales Outstanding | 2566 | 3862 | 4839 | 2432 | 4901 |
Inventory Turnover | 2820 | 5564 | 7836 | 7228 | 5110 |
Days Inventory Outstanding | 9641 | 6070 | 6421 | 8994 | 6212 |
Payables Turnover | 9332 | 9900 | 1164 | 4451 | 2357 |
Days Payables Outstanding | 7216 | 8066 | 9614 | 5990 | 1530 |
Liquidity Ratios | |||||
Current Ratio | 1833 | 6227 | 6023 | 2192 | 9077 |
Quick Ratio | 5473 | 7996 | 7736 | 1780 | 8807 |
Debt Ratios | |||||
Debt-to-Equity Ratio | 1316 | 6899 | 4880 | 6902 | 3831 |
Debt Ratio | 9889 | 1187 | 3087 | 6913 | 6027 |
Interest Coverage Ratio | 7703 | 2774 | 2208 | 5837 | 3928 |
Debt Service Coverage Ratio | 8291 | 7393 | 2472 | 6608 | 1386 |
Net Debt/EBITDA | 7013 | 1633 | 7650 | 8056 | 8751 |
Growth Ratios | |||||
Revenue Growth Rate (CAGR) | 7038 | 9722 | 1263 | 4041 | 9102 |
Earnings Growth Rate (CAGR) | 1999 | 5833 | 1149 | 9895 | 8638 |
Detailed Financials (Income Statement, Balance Sheet, Cashflow Statement)
Compounded Annual Growth Rate of CRADLE LIFE SCIENCES (PHARMA) PRIVATE LIMITED
EBITDA CAGR | Growth |
|---|---|
1 Year | 12% |
3 Year | 706 |
5 Year | 776 |
MSME Payment Delays by CRADLE LIFE SCIENCES (PHARMA) PRIVATE LIMITED
Credit Ratings of CRADLE LIFE SCIENCES (PHARMA) PRIVATE LIMITED
GSTIN Details of CRADLE LIFE SCIENCES (PHARMA) PRIVATE LIMITED
Board of Directors and Signatories of CRADLE LIFE SCIENCES (PHARMA) PRIVATE LIMITED
Board of Directors of CRADLE LIFE SCIENCES (PHARMA) PRIVATE LIMITED
Name | Designation | Status | Appointment Date | Duration |
|---|---|---|---|---|
Director | Current | Feb 13, 2020 | 6 Years 5 Months | |
Director | Current | Feb 13, 2020 | 6 Years 5 Months | |
Director | Current | Feb 13, 2020 | 6 Years 5 Months | |
Director | Current | Feb 13, 2020 | 6 Years 5 Months | |
Director | Current | Feb 13, 2020 | 6 Years 5 Months | |
Director | Current | Feb 13, 2020 | 6 Years 5 Months | |
Director | Current | Feb 13, 2020 | 6 Years 5 Months |
Signatories of CRADLE LIFE SCIENCES (PHARMA) PRIVATE LIMITED
Name | Designation(s) | Status | Appointment Date | Duration |
|---|---|---|---|---|
Director | Current | Feb 13, 2020 | 6 Years 5 Months | |
Director | Current | Feb 13, 2020 | 6 Years 5 Months | |
Director | Current | Feb 13, 2020 | 6 Years 5 Months | |
Director | Current | Feb 13, 2020 | 6 Years 5 Months | |
Director | Current | Feb 13, 2020 | 6 Years 5 Months | |
Director | Current | Feb 13, 2020 | 6 Years 5 Months | |
Director | Current | Feb 13, 2020 | 6 Years 5 Months |
Cross Directorships of CRADLE LIFE SCIENCES (PHARMA) PRIVATE LIMITED
Legal Entity Name | % of Common Directors | Common Director(s) | Open Charge(s) | Active Legal Case(s) |
|---|---|---|---|---|
CRADLE LIFE SCIENCES PRIVATE LIMITED CIN: U24232BR2008PTC014097, India, Active | 947 | 257 | 144 | 864 |
GRAND INDIA JOURNEY PRIVATE LIMITED CIN: U74120DL2008PTC181654, India, Strike off | 649 | 899 | 322 | 217 |
Legal Cases involving CRADLE LIFE SCIENCES (PHARMA) PRIVATE LIMITED
Trademarks of CRADLE LIFE SCIENCES (PHARMA) PRIVATE LIMITED
Patents of CRADLE LIFE SCIENCES (PHARMA) PRIVATE LIMITED
Competitors & Alternates of CRADLE LIFE SCIENCES (PHARMA) PRIVATE LIMITED
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | AmerisourceBergen 1985, Chesterbrook (United States), Public | Drug Corporation | - | 71/100 | |
2nd | Entero Healthcare 2018, Mumbai (India), Public | Operator of an integrated healthcare products distribution platform | $59.7M | 66/100 | |
3rd | Pharmaceutical distributor of temperature-sensitive medicines | $16.6M | 50/100 | ||
4th | Sayre Therapeutics 2015, Bengaluru (India), Series A | Provider of access to innovative therapies for rare and life-threatening diseases | $7.9M | 47/100 | |
5th | Gujarat Terce Laboratories 1985, Gandhinagar (India), Public | Manufacturer of pharmaceutical products across multiple therapeutic areas for global distribution | - | - | 44/100 |
6th | Suresh Pharma Agencies 2009, Chennai (India), Unfunded | Distributor and supplier of pharmaceutical products to customers | - | - | 43/100 |
7th | Flagship Biotech 2008, Mumbai (India), Unfunded | Manufacturer of injectable, oral, and topical pharmaceutical formulations | - | - | 42/100 |
8th | Speciality Medicines 2021, Mumbai (India), Public | Distributor & manufacturer of pharmaceutical medicines | - | - | 41/100 |
9th | Hospimax Healthcare 2009, Delhi (India), Unfunded | Distributor of pharmaceutical products | - | - | 41/100 |
10th | Trimurthi drugs and pharmaceuticals 1994, Hyderabad (India), Public | Traditional company engaged in pharmaceutical distribution and Retail pharmacy | - | - | 40/100 |
276th | Cradle Life Bhilai (India), Unfunded | Provider of pharmaceutical products and skill development programs for individuals | - | - | 19/100 |